Total Payments
$5,730
2024 Payments
$1,799
Companies
30
Transactions
231
Medicare Patients
1,451
Medicare Billing
$73,687
Payment Breakdown by Category
Food & Beverage$5,430 (94.8%)
Education$299.93 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,430 | 228 | 94.8% |
| Education | $299.93 | 3 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sumitomo Pharma America, Inc. | $1,032 | 46 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $954.63 | 28 | $0 (2024) |
| Astellas Pharma US Inc | $833.51 | 30 | $0 (2024) |
| UROVANT SCIENCES INC | $290.91 | 16 | $0 (2022) |
| Antares Pharma, Inc. | $275.42 | 16 | $0 (2024) |
| PFIZER INC. | $261.43 | 9 | $0 (2024) |
| Amgen Inc. | $234.55 | 7 | $0 (2023) |
| UROGEN PHARMA, INC. | $197.80 | 8 | $0 (2024) |
| Myovant Sciences Inc. | $197.71 | 9 | $0 (2022) |
| Blue Earth Diagnostics Limited | $176.68 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,799 | 72 | Sumitomo Pharma America, Inc. ($432.73) |
| 2023 | $1,734 | 69 | Sumitomo Pharma America, Inc. ($599.19) |
| 2022 | $1,870 | 78 | Astellas Pharma US Inc ($429.77) |
| 2021 | $327.16 | 12 | Dendreon Pharmaceuticals LLC ($100.80) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $52.13 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/05/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: HORMONE THERAPY | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/17/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Urology | ||||||
| 10/02/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/01/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: HORMONE THERAPY | ||||||
| 09/23/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 731 | 874 | $111,666 | $34,807 |
| 2022 | 16 | 690 | 938 | $96,064 | $37,708 |
| 2021 | 2 | 30 | 30 | $2,772 | $1,173 |
Total Patients
1,451
Total Services
1,842
Medicare Billing
$73,687
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 179 | 244 | $42,712 | $13,736 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 148 | $36,360 | $11,660 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $21,704 | $6,409 | 29.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 216 | 259 | $6,760 | $2,051 | 30.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,370 | $588.00 | 17.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 90 | 94 | $410.00 | $196.24 | 47.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 48 | 50 | $350.00 | $167.09 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 170 | 227 | $34,050 | $13,533 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 97 | $20,370 | $8,154 | 40.0% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 15 | 90 | $6,300 | $3,124 | 49.6% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2022 | 12 | 36 | $5,040 | $2,504 | 49.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $6,228 | $1,704 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $5,106 | $1,558 | 30.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 135 | 171 | $6,840 | $1,410 | 20.6% |
| 87799 | Detection test by nucleic acid for organism, quantification | Office | 2022 | 15 | 29 | $2,494 | $1,229 | 49.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 26 | $2,340 | $980.55 | 41.9% |
| 87652 | Detection test by nucleic acid for strep (streptococcus, group a), quantification | Office | 2022 | 15 | 15 | $1,260 | $619.68 | 49.2% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2022 | 15 | 15 | $1,050 | $520.75 | 49.6% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2022 | 15 | 15 | $1,050 | $520.75 | 49.6% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2022 | 15 | 15 | $1,050 | $520.75 | 49.6% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2022 | 15 | 15 | $1,050 | $520.75 | 49.6% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2022 | 15 | 15 | $1,050 | $520.75 | 49.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 108 | 131 | $786.00 | $288.16 | 36.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 18 | $2,700 | $1,146 | 42.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 12 | 12 | $72.00 | $27.00 | 37.5% |
About Kevin Snoddy, PA-C
Kevin Snoddy, PA-C is a Physician Assistant healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1902129794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kevin Snoddy, PA-C has received a total of $5,730 in payments from pharmaceutical and medical device companies, with $1,799 received in 2024. These payments were reported across 231 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,430).
As a Medicare-enrolled provider, Snoddy has provided services to 1,451 Medicare beneficiaries, totaling 1,842 services with total Medicare billing of $73,687. Data is available for 3 years (2021–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Henderson, NV
- Active Since 03/08/2010
- Last Updated 06/29/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1902129794
Products in Payments
- GEMTESA (Drug) $1,032
- PROVENGE (Drug) $954.63
- Myrbetriq (Drug) $522.72
- ORGOVYX (Drug) $503.39
- XTANDI (Drug) $246.52
- JELMYTO (Drug) $197.80
- NOCDURNA (Drug) $186.52
- XIAFLEX (Biological) $173.90
- ILLUCCIX (Drug) $158.18
- BOTOX (Biological) $137.83
- XGEVA (Biological) $134.60
- POSLUMA (Drug) $121.81
- PROLARIS (Device) $97.10
- XYOSTED (Drug) $88.90
- Xtandi (Drug) $82.95
- SpeediCath (Device) $69.26
- UROLIFT (Device) $66.98
- ERLEADA (Drug) $55.95
- Axumin (Drug) $54.87
- CAMCEVI (Drug) $35.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Henderson
Anna Liang, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $9,518
Physician Assistant $9,518
Rachel Tennis, Pa-C, PA-C
Physician Assistant — Payments: $8,011
Physician Assistant $8,011
Stephanie Shibata, Pa-C, PA-C
Physician Assistant — Payments: $7,733
Physician Assistant $7,733
Benjamin Reese, Pa-C, PA-C
Physician Assistant — Payments: $6,807
Physician Assistant $6,807
Andrea Alessi, Pa, PA
Physician Assistant — Payments: $6,647
Physician Assistant $6,647
Laurie Michlin, Apn, APN
Physician Assistant — Payments: $6,402
Physician Assistant $6,402